At Spruson & Ferguson, we are dedicated to delivering exceptional service tailored to your needs. With direct filing capabilities in Australia, Singapore, Thailand, Malaysia, Indonesia, Hong Kong and China as well as from our network of trusted agents, our clients benefit from our IP Hub operational model which provides the ability to file in over 25 jurisdictions with a single set of instructions. We are committed to ensuring our advice and services are aligned with the aspirations and business needs of our clients, while delivering value and excellence in every aspect of our service.
Ranging from startups through to Fortune 500 companies and global corporations, our clients span all industries and are at the core of everything we do.
With some of the most highly regarded IP professionals in the region, we have over 480 professionals working collaboratively across disciplines and jurisdictions to ensure clients receive the most informed, efficient, streamlined service and advice that we are known for.
Spruson & Ferguson companies are incorporated entities owned by IPH Limited, a public company that is the holding company for an international network of intellectual property professional services and adjacent businesses which operate under different brands in a range of jurisdictions (each a “Group Business”). The other Group Businesses within the IPH Limited group are AJ Park, Applied Marks, Griffith Hack, Pizzeys Patent & Trade Mark Attorneys, ROBIC and Smart & Biggar.
For the purposes of the Australian and New Zealand Code of Conduct for Trans-Tasman Patent and Trade Marks Attorneys 2018, Spruson & Ferguson Pty Ltd is an incorporated registered patent and trade mark attorney, and a member of an ‘ownership group’ within the meaning of the Code. For further information, see Ownership Group and our Group Relationships Statement .
480+
Employees
130+
Years
190+
IP Professionals
10
Offices
25+
Countries Services
Recognised as a leading intellectual property firm
2025
Best Law Firms – Australia
Australia
Best Lawyers
2023-2025
WTR 1000 – Gold TM prosecution & strategy
Australia
World Trademark Review
2024, 2023
MIP IP Stars – Tier 1 patent prosecution
Australia & Singapore
Managing IP
2024
IAM Patent 1000 – Gold
Australia & Singapore
IAM
2024
Tier 1 – Sydney region
Australia
Doyle’s Guide
2024
Band 3 – Global Guide
Australia
Chambers & Partners
2023
Best IP Firm
Singapore
Singapore Business Awards
2023
Asia-Pacific IP Boutique of the Year
Asia region
Managing IP
2023
Leading IP Specialist Legal Firm
Australia
Australian Enterprise Awards
2022
Top Tier firm for Trade Mark Prosecution work
Australia
Asia IP Trademark Survey
2022
Gold firm for Patent Prosecution
Australia & Singapore
IAM Patent 1000
2022
Top Tier Firm for Patent Prosecution Work
Australia & Singapore
Managing Intellectual Property IP Stars
2022
Top Tier Firm for Trade Mark Prosecution Work
Australia, Hong Kong, Thailand & China
Managing Intellectual Property IP Stars
2021
Top Tier Firm for Patent Prosecution Work
Australia & Singapore
Managing Intellectual Property IP Stars
2021
Asia-Pacific IP Boutique Firm of the Year
Managing Intellectual Property
2021
Top Tier Firm for Trade Mark Prosecution Work
Australia
Managing Intellectual Property IP Stars
2021
Top Tier Firm for Prosecution & Strategy Work
Australia
World Trademark Review
2021
Highly Recommended Firm for Prosecution & Strategy Work
Hong Kong, Indonesia & Singapore
World Trademark Review
2021
Highly Recommended Firm for Enforcement & Litigation Work
On 20 May 2025, Intellectual Property Office of Singapore (IPOS) launched Patents and Trade Marks Acceleration programmes to help applicants receive faster office actions.
Dubbed “SG Patents Fast” and “SG…
On 20 May 2025, Intellectual Property Office of Singapore (IPOS) launched Patents and Trade Marks Acceleration programmes to help…
Over recent years, Australian courts have heard a growing number of challenges to pharmaceutical patent term extensions (PTEs). The decisions in these cases signal an increasingly contentious landscape for…
Over recent years, Australian courts have heard a growing number of challenges to pharmaceutical patent term extensions (PTEs). The…
Key takeaways
The Australian regulatory framework for medical devices provides useful, practical guidance for patenting inventions involving Artificial Intelligence (AI) within the medical technology (medtech) space.
Whilst there is no statutory…
Key takeaways
The Australian regulatory framework for medical devices provides useful, practical guidance for patenting inventions involving Artificial Intelligence (AI)…
As pharmaceutical innovation increasingly targets specific disease subtypes and personalised therapies, patent protection strategies must evolve accordingly—especially in jurisdictions like China, where method of treatment claims are not patentable.
This…
As pharmaceutical innovation increasingly targets specific disease subtypes and personalised therapies, patent protection strategies must evolve accordingly—especially in jurisdictions…
